{"id":"https://openalex.org/W2129870530","doi":"https://doi.org/10.1517/21678707.2015.1077694","title":"Ruxolitinib for treatment of polycythemia vera","display_name":"Ruxolitinib for treatment of polycythemia vera","publication_year":2015,"publication_date":"2015-08-24","ids":{"openalex":"https://openalex.org/W2129870530","doi":"https://doi.org/10.1517/21678707.2015.1077694","mag":"2129870530"},"language":"en","primary_location":{"id":"doi:10.1517/21678707.2015.1077694","doi":"https://doi.org/10.1517/21678707.2015.1077694","is_oa":false,"landing_page_url":"https://doi.org/10.1517/21678707.2015.1077694","pdf_url":null,"source":{"id":"https://openalex.org/S2764525121","display_name":"Expert Opinion on Orphan Drugs","issn_l":"2167-8707","issn":["2167-8707"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","ki-jl-1","poland-40","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Orphan Drugs","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052720982","display_name":"Chad Christian Cherington","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210125099","display_name":"Mayo Clinic in Arizona","ror":"https://ror.org/03jp40720","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chad C Cherington","raw_affiliation_strings":["Mayo Clinic Arizona, 13400 E. Shea Blvd, Scottsdale, AZ 85259, USA +1 480 301 8335; Mesa.ruben@mayo.edu","Mayo Clinic Arizona, 13400 E. Shea Blvd, Scottsdale, AZ 85259, USA +1 480 301 8335"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic Arizona, 13400 E. Shea Blvd, Scottsdale, AZ 85259, USA +1 480 301 8335; Mesa.ruben@mayo.edu","institution_ids":["https://openalex.org/I4210125099"]},{"raw_affiliation_string":"Mayo Clinic Arizona, 13400 E. Shea Blvd, Scottsdale, AZ 85259, USA +1 480 301 8335","institution_ids":["https://openalex.org/I4210125099"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050797998","display_name":"Krisstina L. Gowin","orcid":"https://orcid.org/0000-0002-5670-6630","observed_orcids":["https://orcid.org/0000-0002-5670-6630"]},"institutions":[{"id":"https://openalex.org/I4210125099","display_name":"Mayo Clinic in Arizona","ror":"https://ror.org/03jp40720","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Krisstina L Gowin","raw_affiliation_strings":["Mayo Clinic Arizona, 13400 E. Shea Blvd, Scottsdale, AZ 85259, USA +1 480 301 8335; Mesa.ruben@mayo.edu","Mayo Clinic Arizona, 13400 E. Shea Blvd, Scottsdale, AZ 85259, USA +1 480 301 8335"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic Arizona, 13400 E. Shea Blvd, Scottsdale, AZ 85259, USA +1 480 301 8335; Mesa.ruben@mayo.edu","institution_ids":["https://openalex.org/I4210125099"]},{"raw_affiliation_string":"Mayo Clinic Arizona, 13400 E. Shea Blvd, Scottsdale, AZ 85259, USA +1 480 301 8335","institution_ids":["https://openalex.org/I4210125099"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5039057642","display_name":"Ruben A. Mesa","orcid":"https://orcid.org/0000-0001-5880-7972","observed_orcids":["https://orcid.org/0000-0001-5880-7972"]},"institutions":[{"id":"https://openalex.org/I4210125099","display_name":"Mayo Clinic in Arizona","ror":"https://ror.org/03jp40720","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ruben A Mesa","raw_affiliation_strings":["Mayo Clinic Arizona, 13400 E. Shea Blvd, Scottsdale, AZ 85259, USA +1 480 301 8335; Mesa.ruben@mayo.edu","Mayo Clinic Arizona, 13400 E. Shea Blvd, Scottsdale, AZ 85259, USA +1 480 301 8335"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic Arizona, 13400 E. Shea Blvd, Scottsdale, AZ 85259, USA +1 480 301 8335; Mesa.ruben@mayo.edu","institution_ids":["https://openalex.org/I4210125099"]},{"raw_affiliation_string":"Mayo Clinic Arizona, 13400 E. Shea Blvd, Scottsdale, AZ 85259, USA +1 480 301 8335","institution_ids":["https://openalex.org/I4210125099"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210125099"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.06767965,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"3","issue":"9","first_page":"1085","last_page":"1096"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ruxolitinib","display_name":"ruxolitinib","score":0.9980000257492065},{"id":"https://openalex.org/keywords/polycythemia-vera","display_name":"polycythemia vera","score":1.0},{"id":"https://openalex.org/keywords/myeloproliferative-neoplasms","display_name":"myeloproliferative neoplasms","score":0.9620000123977661},{"id":"https://openalex.org/keywords/jak2-inhibitors","display_name":"JAK2 inhibitors","score":0.7360000014305115},{"id":"https://openalex.org/keywords/hydroxyurea-intolerance","display_name":"hydroxyurea intolerance","score":0.8880000114440918},{"id":"https://openalex.org/keywords/hematocrit-control","display_name":"hematocrit control","score":0.9350000023841858},{"id":"https://openalex.org/keywords/splenomegaly","display_name":"splenomegaly","score":0.9750000238418579},{"id":"https://openalex.org/keywords/symptom-burden","display_name":"symptom burden","score":0.9549999833106995},{"id":"https://openalex.org/keywords/treatment-strategy","display_name":"treatment options","score":0.33799999952316284}],"concepts":[{"id":"https://openalex.org/C2776112149","wikidata":"https://www.wikidata.org/wiki/Q7383611","display_name":"Ruxolitinib","level":4,"score":0.9700913429260254},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9388482570648193},{"id":"https://openalex.org/C2781107747","wikidata":"https://www.wikidata.org/wiki/Q1898104","display_name":"Myeloproliferative neoplasm","level":4,"score":0.8742360472679138},{"id":"https://openalex.org/C2778837598","wikidata":"https://www.wikidata.org/wiki/Q948318","display_name":"Polycythemia vera","level":2,"score":0.8347311615943909},{"id":"https://openalex.org/C2777357209","wikidata":"https://www.wikidata.org/wiki/Q3595842","display_name":"Phlebotomy","level":2,"score":0.7988606691360474},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.438972145318985},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.4294784367084503},{"id":"https://openalex.org/C2780959883","wikidata":"https://www.wikidata.org/wiki/Q111146","display_name":"Hematocrit","level":2,"score":0.41488587856292725},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4127490520477295},{"id":"https://openalex.org/C2780076729","wikidata":"https://www.wikidata.org/wiki/Q1752571","display_name":"Myelofibrosis","level":3,"score":0.3499951660633087},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1517/21678707.2015.1077694","doi":"https://doi.org/10.1517/21678707.2015.1077694","is_oa":false,"landing_page_url":"https://doi.org/10.1517/21678707.2015.1077694","pdf_url":null,"source":{"id":"https://openalex.org/S2764525121","display_name":"Expert Opinion on Orphan Drugs","issn_l":"2167-8707","issn":["2167-8707"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","ki-jl-1","poland-40","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Orphan Drugs","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":83,"referenced_works":["https://openalex.org/W266507365","https://openalex.org/W1557338648","https://openalex.org/W1959044271","https://openalex.org/W1966376466","https://openalex.org/W1968468753","https://openalex.org/W1968931030","https://openalex.org/W1970553871","https://openalex.org/W1975006217","https://openalex.org/W1979832242","https://openalex.org/W1980972742","https://openalex.org/W1982105192","https://openalex.org/W1984285934","https://openalex.org/W1986442976","https://openalex.org/W1988019098","https://openalex.org/W1988060134","https://openalex.org/W1991495650","https://openalex.org/W1998721150","https://openalex.org/W2001901845","https://openalex.org/W2006334728","https://openalex.org/W2006467209","https://openalex.org/W2008970948","https://openalex.org/W2010337668","https://openalex.org/W2011353226","https://openalex.org/W2012686883","https://openalex.org/W2016188929","https://openalex.org/W2018254868","https://openalex.org/W2018618600","https://openalex.org/W2019635573","https://openalex.org/W2020294706","https://openalex.org/W2030868349","https://openalex.org/W2041607731","https://openalex.org/W2047851489","https://openalex.org/W2049145190","https://openalex.org/W2053047123","https://openalex.org/W2057360098","https://openalex.org/W2059200513","https://openalex.org/W2061956129","https://openalex.org/W2066465348","https://openalex.org/W2068302080","https://openalex.org/W2068493370","https://openalex.org/W2069239464","https://openalex.org/W2069821471","https://openalex.org/W2071377073","https://openalex.org/W2072881492","https://openalex.org/W2078678444","https://openalex.org/W2080961746","https://openalex.org/W2085148377","https://openalex.org/W2088702733","https://openalex.org/W2094456737","https://openalex.org/W2094487700","https://openalex.org/W2097692898","https://openalex.org/W2099264304","https://openalex.org/W2107398329","https://openalex.org/W2114995805","https://openalex.org/W2118323591","https://openalex.org/W2119941797","https://openalex.org/W2121743767","https://openalex.org/W2122395736","https://openalex.org/W2123587611","https://openalex.org/W2125783361","https://openalex.org/W2129799496","https://openalex.org/W2133633030","https://openalex.org/W2134919790","https://openalex.org/W2141249732","https://openalex.org/W2147370660","https://openalex.org/W2147666686","https://openalex.org/W2148997726","https://openalex.org/W2149849392","https://openalex.org/W2151757571","https://openalex.org/W2153170459","https://openalex.org/W2154558042","https://openalex.org/W2155484175","https://openalex.org/W2159533809","https://openalex.org/W2161021913","https://openalex.org/W2163831007","https://openalex.org/W2169405856","https://openalex.org/W2171735954","https://openalex.org/W2213345967","https://openalex.org/W2292390406","https://openalex.org/W2319200696","https://openalex.org/W2556415172","https://openalex.org/W2746412264","https://openalex.org/W3200002867"],"related_works":["https://openalex.org/W2102012956","https://openalex.org/W3095103045","https://openalex.org/W2386705151","https://openalex.org/W2912061124","https://openalex.org/W2551573304","https://openalex.org/W2559743233","https://openalex.org/W2114995805","https://openalex.org/W2757452091","https://openalex.org/W2979637502","https://openalex.org/W2292390406"],"abstract_inverted_index":{"Introduction:":[0],"The":[1,16,113],"myeloproliferative":[2],"neoplasm,":[3],"polycythemia":[4],"vera":[5],"(PV)":[6],"significantly":[7],"impacts":[8],"the":[9,28,62,70,89,93],"quality":[10],"of":[11,13,19,30,97],"life":[12],"afflicted":[14],"patients.":[15],"traditional":[17],"therapies":[18,44],"phlebotomy,":[20],"aspirin":[21],"and":[22,78,92,156],"cytoreductive":[23],"medicines":[24],"center":[25],"on":[26,138],"decreasing":[27],"risk":[29],"vascular":[31],"events,":[32],"but":[33,134],"can":[34],"be":[35,173],"inadequate":[36,106,135],"to":[37,72,88,110],"improve":[38,73,79],"symptom":[39,122,136,157],"burden.":[40,158],"Over":[41],"time,":[42],"these":[43],"may":[45,50],"become":[46],"ineffective":[47],"or":[48,108],"patients":[49,82,100,129],"develop":[51],"intolerances":[52],"providing":[53],"a":[54,118],"need":[55],"for":[56,99,120,145],"more":[57],"therapeutic":[58],"options.Areas":[59],"covered:":[60],"Recently,":[61],"randomized":[63],"Phase":[64],"III":[65],"RESPONSE":[66],"trial":[67,115],"has":[68,86],"demonstrated":[69],"ability":[71],"hematocrit":[74,152],"control,":[75,133,153],"reduce":[76],"splenomegaly":[77,155],"symptoms":[80],"in":[81,128,147,151,166,175],"with":[83,101,149],"PV.":[84,176],"This":[85],"led":[87],"US":[90],"FDA":[91],"European":[94],"Commission":[95],"approval":[96],"ruxolitinib":[98,125],"PV":[102,148,167],"who":[103],"have":[104],"an":[105],"response":[107],"intolerance":[109],"hydroxyurea":[111],"(HU).":[112],"RELIEF":[114],"recently":[116],"showed":[117],"trend":[119],"improved":[121],"control":[123,137],"when":[124],"replaced":[126],"HU":[127],"attaining":[130],"good":[131],"disease":[132],"HU.Expert":[139],"opinion:":[140],"Ruxolitinib":[141],"offers":[142],"another":[143],"option":[144],"therapy":[146],"efficacy":[150],"reducing":[154],"Future":[159],"goals":[160],"include":[161],"knowing":[162],"at":[163],"what":[164],"juncture":[165],"should":[168],"Janus":[169],"kinase":[170],"2":[171],"inhibitors":[172],"introduced":[174]},"counts_by_year":[{"year":2022,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}